ENDAVA PLC- SPON ADR (DAVA) Fundamental Analysis & Valuation

NYSE:DAVA • US29260V1052

5.5 USD
-0.02 (-0.36%)
Last: Mar 6, 2026, 08:10 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DAVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

DAVA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. Both the profitability and the financial health of DAVA get a neutral evaluation. Nothing too spectacular is happening here. DAVA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. DAVA Profitability Analysis

1.1 Basic Checks

  • In the past year DAVA was profitable.
  • In the past year DAVA had a positive cash flow from operations.
  • In the past 5 years DAVA has always been profitable.
  • In the past 5 years DAVA always reported a positive cash flow from operatings.
DAVA Yearly Net Income VS EBIT VS OCF VS FCFDAVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1.2 Ratios

  • The Return On Assets of DAVA (-0.32%) is comparable to the rest of the industry.
  • DAVA's Return On Equity of -0.52% is in line compared to the rest of the industry. DAVA outperforms 51.16% of its industry peers.
  • DAVA's Return On Invested Capital of 1.79% is in line compared to the rest of the industry. DAVA outperforms 52.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DAVA is below the industry average of 10.85%.
  • The 3 year average ROIC (5.99%) for DAVA is well above the current ROIC(1.79%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.32%
ROE -0.52%
ROIC 1.79%
ROA(3y)5.4%
ROA(5y)7.77%
ROE(3y)7.6%
ROE(5y)11.34%
ROIC(3y)5.99%
ROIC(5y)9.17%
DAVA Yearly ROA, ROE, ROICDAVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • DAVA's Profit Margin has declined in the last couple of years.
  • DAVA has a Operating Margin of 2.59%. This is comparable to the rest of the industry: DAVA outperforms 45.35% of its industry peers.
  • In the last couple of years the Operating Margin of DAVA has declined.
  • DAVA's Gross Margin of 23.56% is on the low side compared to the rest of the industry. DAVA is outperformed by 74.42% of its industry peers.
  • DAVA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.59%
PM (TTM) N/A
GM 23.56%
OM growth 3Y-34.74%
OM growth 5Y-9.2%
PM growth 3Y-39.96%
PM growth 5Y-13.58%
GM growth 3Y-8.99%
GM growth 5Y-2.39%
DAVA Yearly Profit, Operating, Gross MarginsDAVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DAVA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DAVA is destroying value.
  • Compared to 1 year ago, DAVA has less shares outstanding
  • The number of shares outstanding for DAVA has been increased compared to 5 years ago.
  • The debt/assets ratio for DAVA is higher compared to a year ago.
DAVA Yearly Shares OutstandingDAVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
DAVA Yearly Total Debt VS Total AssetsDAVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • DAVA has an Altman-Z score of 2.25. This is not the best score and indicates that DAVA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.25, DAVA perfoms like the industry average, outperforming 48.84% of the companies in the same industry.
  • DAVA has a debt to FCF ratio of 5.87. This is a neutral value as DAVA would need 5.87 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.87, DAVA is in line with its industry, outperforming 53.49% of the companies in the same industry.
  • A Debt/Equity ratio of 0.42 indicates that DAVA is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.42, DAVA is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 5.87
Altman-Z 2.25
ROIC/WACC0.27
WACC6.68%
DAVA Yearly LT Debt VS Equity VS FCFDAVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • DAVA has a Current Ratio of 2.39. This indicates that DAVA is financially healthy and has no problem in meeting its short term obligations.
  • DAVA has a Current ratio of 2.39. This is in the better half of the industry: DAVA outperforms 68.60% of its industry peers.
  • DAVA has a Quick Ratio of 2.39. This indicates that DAVA is financially healthy and has no problem in meeting its short term obligations.
  • DAVA's Quick ratio of 2.39 is fine compared to the rest of the industry. DAVA outperforms 68.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.39
DAVA Yearly Current Assets VS Current LiabilitesDAVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DAVA Growth Analysis

3.1 Past

  • The earnings per share for DAVA have decreased strongly by -10.44% in the last year.
  • DAVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.54% yearly.
  • The Revenue has decreased by -2.04% in the past year.
  • The Revenue has been growing by 17.08% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.44%
EPS 3Y-16.39%
EPS 5Y2.54%
EPS Q2Q%-46.61%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y5.65%
Revenue growth 5Y17.08%
Sales Q2Q%-5.88%

3.2 Future

  • Based on estimates for the next years, DAVA will show a small growth in Earnings Per Share. The EPS will grow by 3.51% on average per year.
  • Based on estimates for the next years, DAVA will show a small growth in Revenue. The Revenue will grow by 1.29% on average per year.
EPS Next Y-30.3%
EPS Next 2Y-7.38%
EPS Next 3Y-0.79%
EPS Next 5Y3.51%
Revenue Next Year-4.65%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.56%
Revenue Next 5Y1.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DAVA Yearly Revenue VS EstimatesDAVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
DAVA Yearly EPS VS EstimatesDAVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

7

4. DAVA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.62, the valuation of DAVA can be described as very cheap.
  • Based on the Price/Earnings ratio, DAVA is valued cheaper than 93.02% of the companies in the same industry.
  • DAVA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.29.
  • With a Price/Forward Earnings ratio of 4.23, the valuation of DAVA can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DAVA indicates a rather cheap valuation: DAVA is cheaper than 94.19% of the companies listed in the same industry.
  • DAVA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.57.
Industry RankSector Rank
PE 4.62
Fwd PE 4.23
DAVA Price Earnings VS Forward Price EarningsDAVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.37% of the companies in the same industry are more expensive than DAVA, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, DAVA is valued cheaply inside the industry as 96.51% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.12
EV/EBITDA 6.2
DAVA Per share dataDAVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.82
EPS Next 2Y-7.38%
EPS Next 3Y-0.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DAVA Dividend Analysis

5.1 Amount

  • DAVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DAVA Fundamentals: All Metrics, Ratios and Statistics

ENDAVA PLC- SPON ADR

NYSE:DAVA (3/6/2026, 8:10:36 PM)

5.5

-0.02 (-0.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-19
Earnings (Next)05-04
Inst Owners62.3%
Inst Owner Change-21.04%
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap290.63M
Revenue(TTM)743.90M
Net Income(TTM)-2.95M
Analysts74.67
Price Target10.12 (84%)
Short Float %4.29%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.45%
Min EPS beat(2)-19.17%
Max EPS beat(2)2.26%
EPS beat(4)3
Avg EPS beat(4)-2.29%
Min EPS beat(4)-19.17%
Max EPS beat(4)4.93%
EPS beat(8)6
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)6.91%
EPS beat(16)13
Avg EPS beat(16)6.16%
Revenue beat(2)1
Avg Revenue beat(2)-1.95%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)0.12%
Revenue beat(4)1
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-4.03%
Max Revenue beat(4)0.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.31%
Revenue beat(12)1
Avg Revenue beat(12)-2.01%
Revenue beat(16)2
Avg Revenue beat(16)-1.52%
PT rev (1m)-12.14%
PT rev (3m)-28.2%
EPS NQ rev (1m)-7.62%
EPS NQ rev (3m)-7.62%
EPS NY rev (1m)-1%
EPS NY rev (3m)-9.58%
Revenue NQ rev (1m)-0.76%
Revenue NQ rev (3m)-0.84%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-2.29%
Valuation
Industry RankSector Rank
PE 4.62
Fwd PE 4.23
P/S 0.29
P/FCF 5.12
P/OCF 3.83
P/B 0.38
P/tB N/A
EV/EBITDA 6.2
EPS(TTM)1.19
EY21.64%
EPS(NY)1.3
Fwd EY23.62%
FCF(TTM)1.07
FCFY19.54%
OCF(TTM)1.44
OCFY26.1%
SpS18.81
BVpS14.3
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)1.82
Graham Number19.57
Profitability
Industry RankSector Rank
ROA -0.32%
ROE -0.52%
ROCE 2.36%
ROIC 1.79%
ROICexc 1.95%
ROICexgc 8.57%
OM 2.59%
PM (TTM) N/A
GM 23.56%
FCFM 5.71%
ROA(3y)5.4%
ROA(5y)7.77%
ROE(3y)7.6%
ROE(5y)11.34%
ROIC(3y)5.99%
ROIC(5y)9.17%
ROICexc(3y)7.62%
ROICexc(5y)12.23%
ROICexgc(3y)23.85%
ROICexgc(5y)34.64%
ROCE(3y)7.91%
ROCE(5y)12.11%
ROICexgc growth 3Y-38.47%
ROICexgc growth 5Y-7.84%
ROICexc growth 3Y-47.64%
ROICexc growth 5Y-20.33%
OM growth 3Y-34.74%
OM growth 5Y-9.2%
PM growth 3Y-39.96%
PM growth 5Y-13.58%
GM growth 3Y-8.99%
GM growth 5Y-2.39%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 5.87
Debt/EBITDA 3.66
Cap/Depr 31.64%
Cap/Sales 1.92%
Interest Coverage 2.03
Cash Conversion 88.21%
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.39
Altman-Z 2.25
F-Score6
WACC6.68%
ROIC/WACC0.27
Cap/Depr(3y)21.99%
Cap/Depr(5y)27.65%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.28%
Profit Quality(3y)209.96%
Profit Quality(5y)189.49%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.44%
EPS 3Y-16.39%
EPS 5Y2.54%
EPS Q2Q%-46.61%
EPS Next Y-30.3%
EPS Next 2Y-7.38%
EPS Next 3Y-0.79%
EPS Next 5Y3.51%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y5.65%
Revenue growth 5Y17.08%
Sales Q2Q%-5.88%
Revenue Next Year-4.65%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.56%
Revenue Next 5Y1.29%
EBIT growth 1Y233.55%
EBIT growth 3Y-31.05%
EBIT growth 5Y6.31%
EBIT Next Year-3.26%
EBIT Next 3Y8.84%
EBIT Next 5Y5.85%
FCF growth 1Y-58.36%
FCF growth 3Y-23.34%
FCF growth 5Y9.6%
OCF growth 1Y-48.59%
OCF growth 3Y-24.1%
OCF growth 5Y6.85%

ENDAVA PLC- SPON ADR / DAVA FAQ

What is the fundamental rating for DAVA stock?

ChartMill assigns a fundamental rating of 4 / 10 to DAVA.


What is the valuation status of ENDAVA PLC- SPON ADR (DAVA) stock?

ChartMill assigns a valuation rating of 7 / 10 to ENDAVA PLC- SPON ADR (DAVA). This can be considered as Undervalued.


What is the profitability of DAVA stock?

ENDAVA PLC- SPON ADR (DAVA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for DAVA stock?

The Price/Earnings (PE) ratio for ENDAVA PLC- SPON ADR (DAVA) is 4.62 and the Price/Book (PB) ratio is 0.38.


Can you provide the financial health for DAVA stock?

The financial health rating of ENDAVA PLC- SPON ADR (DAVA) is 5 / 10.